Objective: The DIRAS2 gene is associated with ADHD, but its function is largely unknown. Thus, we aimed to explore the genes and molecular pathways affected by DIRAS2. Method: Using short hairpin RNAs, we downregulated Diras2 in murine hippocampal primary cells. Gene expression was analyzed by microarray and affected pathways were identified. We used quantitative real-time polymerase chain reaction (qPCR) to confirm expression changes and analyzed enrichment of differentially expressed genes in an ADHD GWAS (genome-wide association studies) sample. Results:Diras2 knockdown altered expression of 1,612 genes, which were enriched for biological processes involved in neurodevelopment. Expression changes were confirmed for 33 out of 88 selected genes. These 33 genes showed significant enrichment in ADHD patients in a gene-set-based analysis. Conclusion: Our findings show that Diras2 affects numerous genes and thus molecular pathways that are relevant for neurodevelopmental processes. These findings may further support the hypothesis that DIRAS2 is linked to etiological processes underlying ADHD.
AlexaA.RahnenfuhrerJ.LengauerT. (2006). Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics, 22, 1600-1607. doi:10.1093/bioinformatics/btl140
2.
AshersonP.ZhouK.AnneyR. J. L.FrankeB.BuitelaarJ.EbsteinR.. . . FaraoneS. V. (2008). A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Molecular Psychiatry, 13, 514-521. doi:10.1038/sj.mp.4002140
3.
AutonA.AbecasisG. R.AltshulerD. M.DurbinR. M.BentleyD. R.ChakravartiA.. . . LuY. (2015). A global reference for human genetic variation. Nature, 526, 68-74. doi:10.1038/nature15393
4.
BrummelkampT. R.BernardsR.AgamiR. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-553. doi:10.1126/science.1068999
5.
CandemirE.KollertL.WeißflogL.GeisM.MüllerA.PostA. M.. . . FreudenbergF. (2016). Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology. European Neuropsychopharmacology, 26, 741-755. doi:10.1016/j.euroneuro.2016.01.008
6.
CarmellM. A.XuanZ.ZhangM. Q.HannonG. J. (2002). The Argonaute family: Tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes & Development, 16, 2733-2742. doi:10.1101/gad.1026102
7.
Cázares-OrdoñezV.PardoL. A. (2017). Kv10.1 potassium channel: From the brain to the tumors. Biochemistry and Cell Biology, 95, 531-536. doi:10.1139/bcb-2017-0062
8.
ChiocchettiA. G.HaslingerD.SteinJ. L.delaTorre-UbietaL.CocchiE.RothämelT.. . . FreitagC. M. (2016). Transcriptomic signatures of neuronal differentiation and their association with risk genes for autism spectrum and related neuropsychiatric disorders. Translational Psychiatry, 6(8), e864. doi:10.1038/tp.2016.119
9.
de LeeuwC. A.MooijJ. M.HeskesT.PosthumaD. (2015). MAGMA: Generalized gene-set analysis of GWAS data. PLoS Computational Biology, 11(4), e1004219. doi:10.1371/journal.pcbi.1004219
10.
DemontisD.WaltersR. K.MartinJ.MattheisenM.AlsT. D.AgerboE.. . . NealeB. M. (2018) Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics. doi: 10.1038/s41588-018-0269-7.
11.
DillH.LinderB.FehrA.FischerU. (2012). Intronic miR-26b controls neuronal differentiation by repressing its host transcript, ctdsp2. Genes & Development, 26, 25-30. doi:10.1101/gad.177774.111
12.
EpsteinJ. N.LorenR. E. A. (2013). Changes in the definition of ADHD in DSM-5: Subtle but important. Neuropsychiatry, 3, 455-458. doi:10.2217/npy.13.59
FoltzS. J.LuanJ.CallJ. A.PatelA.PeissigK. B.FortunatoM. J.BeedleA. M. (2016). Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy. Skeletal Muscle, 6, 20. doi:10.1186/s13395-016-0091-9
16.
GrünewaldL.BeckerN.CamphausenA.O’LearyA.LeschK.-P.FreudenbergF.ReifA. (2018). Expression of the ADHD candidate gene Diras2 in the brain. Journal of Neural Transmission, 125, 913-923. doi:10.1007/s00702-018-1867-3
17.
GrünewaldL.LandaasE. T.GeisslerJ.WeberH.QuastC.RöhS.. . . ReifA. (2016). Functional impact of an ADHD-associated DIRAS2 promoter polymorphism. Neuropsychopharmacology, 41, 3025-3031. doi:10.1038/npp.2016.113
18.
HaslingerD.WaltesR.YousafA.LindlarS.SchneiderI.LimC. K.. . . ChiocchettiA. G. (2018). Loss of the Chr16p11.2 ASD candidate gene QPRT leads to aberrant neuronal differentiation in the SH-SY5Y neuronal cell model 06 biological sciences 0604 genetics. Molecular Autism, 9, 1-17. doi:10.1186/s13229-018-0239-z
KimS.LehtinenM. K.SessaA.ZappaterraM. W.ChoS.-H.GonzalezD.. . . WalshC. A. (2010). The apical complex couples cell fate and cell survival to cerebral cortical development. Neuron, 66, 69-84. doi:10.1016/j.neuron.2010.03.019
23.
KimY.TeylanM. A.BaronM.SandsA.NairnA. C.GreengardP. (2009). Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbens. Proceedings of the National Academy of Sciences of the United States of America, 106, 2915-2920. doi:10.1073/pnas.0813179106
24.
KontaniK.TadaM.OgawaT.OkaiT.SaitoK.ArakiY.KatadaT. (2002). Di-Ras, a distinct subgroup of ras family GTPases with unique biochemical properties. Journal of Biological Chemistry, 277, 41070-41078. doi:10.1074/jbc.M202150200
25.
LeeH.EngelU.RuschJ.ScherrerS.SheardK.Van VactorD. (2004). The microtubule plus end tracking protein Orbit/MAST/CLASP acts downstream of the tyrosine kinase Abl in mediating axon guidance. Neuron, 42, 913-926. doi:10.1016/j.neuron.2004.05.020
26.
LeschK.-P.TimmesfeldN.RennerT. J.HalperinR.RöserC.NguyenT. T.. . . JacobC. (2008). Molecular genetics of adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. Journal of Neural Transmission, 115, 1573-1585. doi:10.1007/s00702-008-0119-3
27.
LevineA. J.OrenM. (2009). The first 30 years of p53: Growing ever more complex. Nature Reviews Cancer, 9, 749-758. doi:10.1038/nrc2723
28.
MartinJ.WaltersR. K.DemontisD.MattheisenM.LeeS. H.RobinsonE.. . . NealeB. M. (2017). A genetic investigation of sex bias in the prevalence of attention deficit/hyperactivity disorder. Biological Psychiatry, 83, 1044-1053. doi: 10.1016/J.BIOPSYCH.2017.11.026
29.
MatthewsM.NiggJ. T.FairD. A. (2014). Attention deficit hyperactivity disorder. Current Topics in Behavioral Neurosciences, 16, 235-266. doi:10.1007/7854_2013_249
30.
MorettoE.MurruL.MartanoG.SassoneJ.PassafaroM. (2018). Glutamatergic synapses in neurodevelopmental disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 84, 328-342. doi:10.1016/J.PNPBP.2017.09.014
31.
NakanishiH.ObaishiH.SatohA.WadaM.MandaiK.SatohK.. . . TakaiY. (1997). Neurabin: A novel neural tissue-specific actin filament-binding protein involved in neurite formation. The Journal of Cell Biology, 139, 951-961.
32.
NaughtonB. J.HanD. D.GuH. H. (2011). Fluorescence-based evaluation of shRNA efficacy. Analytical Biochemistry, 417, 162-164. doi:10.1016/j.ab.2011.06.008
33.
NealeB. M.MedlandS. E.RipkeS.AshersonP.FrankeB.LeschK.-P.. . . NelsonS. (2010). Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 884-897. doi:10.1016/j.jaac.2010.06.008
34.
NiggJ.NikolasM.BurtS. A. (2010). Measured gene by environment interaction in relation to attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 863-873. doi:10.1016/j.jaac.2010.01.025
35.
OliverC. J.Terry-LorenzoR. T.ElliottE.BloomerW. A. C.LiS.BrautiganD. L.. . . ShenolikarS. (2002). Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: The neurabin I/PP1 complex regulates cell morphology. Molecular and Cellular Biology, 22, 4690-4701.
36.
PereiraA. L.PereiraA. J.MaiaA. R. R.DrabekK.SayasC. L.HergertP. J.. . . MaiatoH. (2006). Mammalian CLASP1 and CLASP2 cooperate to ensure mitotic fidelity by regulating spindle and kinetochore function. Molecular Biology of the Cell, 17, 4526-4542. doi:10.1091/mbc.E06-07-0579
37.
ReifA.NguyenT. T.WeißflogL.JacobC. P.RomanosM.RennerT. J.. . . LeschK.-P. (2011). DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. Neuropsychopharmacology, 36, 2318-2327. doi:10.1038/npp.2011.120
38.
RomanosM.FreitagC.JacobC.CraigD. W.DempfleA.NguyenT. T.. . . LeschK. P. (2008). Genome-wide linkage analysis of ADHD using high-density SNP arrays: Novel loci at 5q13.1 and 14q12. Molecular Psychiatry, 13, 522-530. doi:10.1038/mp.2008.12
39.
SmythG. K. (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology, 3(1), 3. doi:10.2202/1544-6115.1027
40.
SuttonM. N.YangH.HuangG. Y.FuC.PontikosM.WangY.. . . BastR. C. (2018). RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells. Autophagy, 14, 637-653. doi:10.1080/15548627.2018.1427022
41.
TakeiN.NawaH. (2014). mTOR signaling and its roles in normal and abnormal brain development. Frontiers in Molecular Neuroscience, 7, 28. doi:10.3389/fnmol.2014.00028
WuS.MikhailovA.Kallo-HoseinH.HaraK.YonezawaK.AvruchJ. (2002). Characterization of ubiquilin 1, an mTOR-interacting protein. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1542(1–3), 41-56. doi:10.1016/S0167-4889(01)00164-1
44.
YeoM.LeeS. K.LeeB.RuizE. C.PfaffS. L.GillG. N. (2005). Small CTD phosphatases function in silencing neuronal gene expression. Science, 307, 596-600. doi:10.1126/science.1100801
45.
YuJ.-Y.DeRuiterS. L.TurnerD. L. (2002). RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 99, 6047-6052. doi:10.1073/pnas.092143499
46.
YuY.XuF.PengH.FangX.ZhaoS.LiY.. . . BastR. C. (1999). NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proceedings of the National Academy of Sciences of the United States of America, 96, 214-219. doi:10.1073/pnas.96.1.214
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
